ROBIN HOWARD W

President & CEO

ROBIN HOWARD W has filed 9 SEC Form 4 filings (22 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Aug 20, 2026.

On the most recent filing, ROBIN HOWARD W is listed as President & CEO at NEKTAR THERAPEUTICS. Inside the rolling window, ROBIN HOWARD W reported no open-market purchases and 9 open-market sales totaling $2.2M in NKTR. The largest disclosed transaction in the window is a sale of 10,000 NKTR shares on Jun 17, 2026, worth $612K.

Companies traded

Other insiders at NKTR

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$2.2M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
NKTRSale$30KAug 20SEC ↗
NKTRSale$603KJun 18SEC ↗
NKTRSale$612KJun 18SEC ↗
NKTRSale$29KMay 21SEC ↗
NKTRSale$31KFeb 20SEC ↗
NKTRSale$120KNov 25SEC ↗
NKTRSale$311KSep 11SEC ↗
NKTRSale$174KSep 8SEC ↗
NKTRSale$257KSep 8SEC ↗
Showing 1–9 of 9
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Sep 2, 2025NKTRSale$45K
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has ROBIN HOWARD W made?

ROBIN HOWARD W has filed 9 SEC Form 4 filings (22 transaction rows) across 1 company since 2025.

Which companies does ROBIN HOWARD W trade?

ROBIN HOWARD W has filed SEC Form 4 disclosures for 1 company, including NKTR.

When was ROBIN HOWARD W's most recent SEC Form 4 filing?

ROBIN HOWARD W's most recent SEC Form 4 filing on Tracefour is dated Aug 20, 2026.

What is ROBIN HOWARD W's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, ROBIN HOWARD W is listed as President & CEO.

What is ROBIN HOWARD W's total buy and sell value in the current window?

Inside the rolling retention window, ROBIN HOWARD W bought $0 and sold $2.2M based on SEC Form 4 filings.

What was ROBIN HOWARD W's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 10,000 NKTR shares on 2026-06-17, worth $612K, per SEC Form 4 filings.